Smith & Nephew PLC (SNNUF) stock analysis
Close on Oct 19, 2026Market cap –P/E 18.6Yield –
StockData Score
Prices as of Oct 30, 2026How the score works
Weak6 of 30 checks passed
Smith & Nephew passes 6 of the 30 checks behind our score; 19 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 0/6
- Growth
- 1/6
- Past performance
- 1/6
- Financial health
- 4/6
- Dividend
- 0/6
What stands out
Return on capital over 10%
Return on invested capital was 13.0%, above the 10% that usually covers the cost of capital.
Low debt
Debt is 9.8% of shareholders' equity, under the 40% we consider low.
EPS growing 10%+ a year
Diluted EPS grew 41.1% a year over the last three fiscal years.
Interest well covered
Operating income covers interest expense 5.7 times.
What to watch
Revenue growing under 10% a year
Revenue grew 5.7% a year over the last three fiscal years, short of the 10% we look for.
Growing slower than the industry
Revenue grew 6.1% over the last twelve months; the Surgical, Medical, and Dental Instruments and Supplies median is 10.4%.
Gross margin slipping
Gross margin was 68.0% over the last twelve months, against 69.6% a year earlier.
Debt rising against equity
Debt to equity rose from 5.3% five years ago to 9.8%.
Valuation0/6
P/E against its history
Not enough price and earnings history to compare.
P/E against the industry
Needs positive earnings and enough profitable companies in the industry.
EV/EBITDA against its history
Needs positive EBITDA and price history.
P/B against the industry
Needs positive book value.
Price against fair value
We could not estimate a fair value: it needs at least two valuation methods with positive inputs.
Margin of safety
Depends on the fair value estimate.
Growth1/6
Revenue growing under 10% a year
Revenue grew 5.7% a year over the last three fiscal years, short of the 10% we look for.
EPS growing 10%+ a year
Diluted EPS grew 41.1% a year over the last three fiscal years.
Earnings acceleration
Needs positive net income now, a year ago and five years ago.
Growing slower than the industry
Revenue grew 6.1% over the last twelve months; the Surgical, Medical, and Dental Instruments and Supplies median is 10.4%.
Company guidance
No outlook found in earnings releases from the last twelve months.
Gross margin slipping
Gross margin was 68.0% over the last twelve months, against 69.6% a year earlier.
Past performance1/6
Return on equity
Needs positive equity and five years of results.
Return on capital over 10%
Return on invested capital was 13.0%, above the 10% that usually covers the cost of capital.
Return on equity against the industry
Needs positive equity.
Earnings over 5 years
Needs positive net income five years ago and in the latest year.
Net margin against its history
Needs five years of revenue and net income.
Net margin against the industry
Needs revenue and net income.
Financial health4/6
Low debt
Debt is 9.8% of shareholders' equity, under the 40% we consider low.
Debt rising against equity
Debt to equity rose from 5.3% five years ago to 9.8%.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 253% of total debt.
Interest well covered
Operating income covers interest expense 5.7 times.
Short-term assets cover short-term debts
Current assets are 2.14 times current liabilities.
Bankruptcy risk (Altman Z)
Needs market value, working capital and retained earnings.
Dividend0/6
No dividend
Smith & Nephew has not paid a dividend in the last twelve months.
Yield against Treasuries
No dividend.
Yield against the market
No dividend.
Dividend stability
No dividend.
Earnings cover
No dividend.
Cash-flow cover
No dividend.
Fair value
How we estimate itWe don't publish a fair value for Smith & Nephew. It needs a US-dollar share price, at least two valuation methods with positive inputs (earnings, EBITDA, book value or sales) and, for companies with several share classes, classes that trade at the same price.
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $34.48M
- Value traded per 1% price move
- $37.56M
Downside
Low risk
- Typical loss in a bad month
- 12.8%
- Volatility (annualized)
- 29%
- Sharpe ratio, 1 year
- -0.75
- Beta to the S&P 500 (5Y)
- 0.63
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2014 to 2025
Gross margin
Operating margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +6.1% | +5.7% | +6.2% | +2.9% | |
| Gross profit | +3.6% | +4.5% | +5.8% | +1.8% | |
| Operating income | +20.9% | +20.8% | +21.9% | +2.4% | |
| EPS, diluted | +52.3% | +41.1% | +6.9% | +4.6% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Current ratio | 1.88 | 2.76 | 2.57 | |
| Debt to equity | 0.42 | – | – | |
| Net debt to EBITDA | 1.33× | – | – | |
| Interest coverage | 15.4× | 4.8× | 5.7× | |
| Inventory turnover | 1.0× | 0.8× | 0.9× | |
| Diluted shares | 893M | 877M | 873M |
Cash use needs five years of cash flow figures
Smith & Nephew does not report operating cash flow and capital expenditure for each of the last five fiscal years.
DuPont needs revenue, assets and equity
This company does not report all three for consecutive years.
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero–
- Cash generatingOperating cash flow above zero$1.29B
- Return on assets improvedROA up on the prior year– → –
- Earnings backed by cashOperating cash flow above net income$1.29B vs –
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose2.89 → 2.57
- No dilutionShare count did not rise876M → 873M
- Gross margin improvedGross margin up on the prior year69.64% → 68.01%
- More efficientAsset turnover rose0.58 → 0.60